Clinical Trial Update: Use of Angiotensin-(1-7) in COVID-19 [Phase 1, Phase 2]

View source ↗

Summary

A combined Phase 1/Phase 2 trial evaluating Angiotensin-(1-7) for COVID-19 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection
• Respiratory Failure

Drugs mentioned

• Angiotensin-(1-7) (Angiotensin-(1-7))

Snippet

Sponsor: Erasme University Hospital | Conditions: Infection, Coronavirus, Respiratory Failure | Phase 1, Phase 2 | Status: COMPLETED